PTC THERAPEUTICS, INC. — Director's Dealing 2014

Mar 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-03-18

Reporting Person: Jacobson Allan Steven (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-18	Common Stock	S	3816	$30.83	Disposed	34264	Direct
2014-03-18	Common Stock	S	3800	$31.54	Disposed	30464	Direct

Footnotes

F1: The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 26, 2013 for the primary purpose of covering tax obligations associated with a restricted stock vesting event.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $30.43 to $31.42 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $31.44 to $31.71 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.